New Delhi [India], December 8: Sebia India Private Limited has been named the Top Emerging MedTech Company at the BioSpectrum Excellence Awards 2025, recognizing its growing leadership and innovation in the Indian diagnostics sector.
The award was presented by Dr. Jitendra Singh, Hon’ble Minister of Science & Technology, Government of India, at a ceremony held at the India Habitat Centre, New Delhi. Sebia was selected by an independent jury panel consisting of experts from academia, investment, policy, and healthcare consulting.
The recognition coincides with Sebia India completing six years of successful operations in the country.
Speaking at the event, Ms. Heejin Roh, Vice President – Commercial Operations, Asia-Pacific, Sebia, said, “This is a proud moment as we continue to provide advanced diagnostic solutions to hospitals and laboratories across India. We thank our customers and partners for their trust and support.” She added that the company will continue expanding its technology offerings and scientific collaborations in the Indian market.
Sebia is a global leader in specialty diagnostics, known for its solutions in multiple myeloma, hemoglobinopathies, HbA1c testing, newborn screening, and autoimmune diseases, supported by advanced platforms like capillary electrophoresis systems and the Alegria analyzer.
If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.
